The National Health Service (NHS) in England may soon implement a new device that could change the lives of thousands of people.
the reason? The health center will likely offer a technology to automatically control sugar in people with type 1 diabetes. According to the BBC, it is estimated that more than 100,000 people will benefit.
But that is not all. Some scientists have recently identified that this device, known as an artificial pancreas, May also work in people with type 2 diabetes,
Type 2 diabetes is the most common form of the disease, affecting approximately 415 million people worldwide.
On the other hand, 90% of the 4 million people with diabetes in England correspond to type 2 according to Diabetes UK.
In the framework of an investigation by the University of Cambridge, experts were able to show that the equipment of insulin that came to improve glucose control in “closed loop” patients“Without increasing hypoglycemia compared to standard insulin therapy,” the study indicates.
This may be a safer and more effective way to improve control of type 2 diabetes in these patients.
In this disease, the standard therapy is one in which patients have to inject insulin daily. However, this method may leave unwanted effects such as pain, nerve damage, and the risk of amputation.
“Many people with type 2 diabetes struggle to control their blood sugar levels with current treatments”said Charlotte Boughton, lead author of the research.
In that line, he added that “the artificial pancreas may provide a safe and effective approach to helping them, and the technology is easy to use and can be safely implemented at home.”
The operation of the “closed loop” system is as follows: uses a sensor and an insulin pump that comes with a Application Developed by research team, It should be kept in the body of the patient to control the blood sugar level.
Through algorithms, the app predicts how much insulin a person needs to reach a healthy glucose level.
To conduct the study, the University of Cambridge called on 26 patients. Half of the group tested the device, while the other half stuck to their regular treatment of insulin injections.
It was found during the tests Those who tried the automated device spent 66% of the time in their blood sugar target range.compared to the 32% presented by those with standard treatment.
The investigation found that none of the patients experienced extremely low blood sugar (hypoglycemia) during the trial.
In addition, the reflection of Participants reported they were satisfied with a device that could automatically monitor their glucose levels, In fact, nearly 89% admitted that they spent less time managing type 2 diabetes than they normally do.